-
Kangchen Pharmaceutical's KC1036 entered Phase Ib/II clinical study for the treatment of advanced digestive system tumors
Time of Update: 2022-05-02
On February 23, Kangchen Pharmaceutical issued an announcement saying that recently, Kangchen Pharmaceutical's "Phase Ib/II clinical study plan to evaluate the efficacy and safety of KC1036 in the treatment of advanced recurrent or metastatic digestive system tumors" was published in the Chinese Academy of Medical Sciences.
-
The three major varieties are out, and the top 10 best-selling drugs in 2022 will undergo great changes
Time of Update: 2022-03-09
The biological targeting agent Dabitux may rank among the top 10 best-selling drugs in the world for the first time this year with a gratifying sales growth rate, while the anticoagulants Xarelto/Xarelto (rivaroxaban) and small molecules, which were at the bottom last year The BTK inhibitor Yike/Imbruvica (ibrutinib) and the ophthalmic biologic drug Aliya/Eylea (aflibercept), which are about to be impacted by biosimilars, were tragically eliminated .
-
2018 China's top 100 fertilizer companies released
Time of Update: 2022-02-22
?? Hubei Yihua Group, Yuntianhua Group, Wengfu Group, Yangmei Chemical, Guizhou Kailin, Shandong Lubei, Shi Kefeng, Jin Yimeng, Jinzhengda, and China Salt Anhui Red Sifang occupy the top 100 fertilizer companies list ten.
-
The global polyethylene market is expected to have oversupply in the first half of next year
Time of Update: 2022-02-03
In addition to returning to normal conditions after the US hurricanes hit southwestern Louisiana and southeastern Texas in August and October, new polyethylene production capacity in Asia is also ready to start.
-
NMPA approves the listing of Xuanqijian Bone Tablets, Qizhi Yishen Capsules and Kunxinning Granules
Time of Update: 2021-12-03
Recently, the National Medical Products Administration approved the marketing registration application for three innovative Chinese medicines: Xuanqijiangu Pian, Qizhi Yishen Capsule and Kunxinning Granules .
Recently, the National Medical Products Administration approved the marketing registration application for three innovative Chinese medicines: Xuanqijiangu Pian, Qizhi Yishen Capsule and Kunxinning Granules .
-
The fluorine chemical sector linearly increases the multi-fluorine daily limit
Time of Update: 2021-11-28
Flush data shows that as of 10:06, the fluorine chemical sector index rose by 1.
[Copyright and Disclaimer] All copyrighted works belonging to this website must be authorized when reprinting and indicate the source "China Industrial Economic Information Network".
-
When will coal prices stabilize
Time of Update: 2021-11-18
Affected by the supply guarantee policy during the Spring Festival, medium and large coal mines in the main production areas maintained normal production, and the overall supply level was more favorable than in previous years.
-
China’s first ambroxol hydrochloride spray was officially approved, Luoxin Pharmaceutical’s exclusive research and development fills the gap in the children’s drug market
Time of Update: 2021-08-13
As the first and only child-specific expectorant spray in China, the approval of ambroxol hydrochloride spray is expected to solve the problem that existing dosage forms cannot meet clinical needs, and enable high-quality innovative drugs to better serve The field of medicine for children in China .
-
Announcement of the State Food and Drug Administration on the cancellation of registration certificates for phenolphthalein tablets and phenolphthalein buccal tablets (No. 6 of 2021
Time of Update: 2021-07-07
According to Article 83 of the "Drug Administration Law of the People's Republic of China", the State Drug Administration organized a post-marketing evaluation of phenolphthalein tablets and phenolphthalein lozenges.
Attachment: List of manufacturers of phenolphthalein tablets and phenolphthalein lozenges State Food and Drug Administration January 8, 2021 Annex to Announcement No.
-
China’s imports of thermal coal fell by 33.61% in April, lignite fell by 18.1
Time of Update: 2021-06-05
The latest data released by the General Administration of Customs shows that in April 2021, China imported 9.
64 million tons of thermal coal (including bituminous coal and sub-bituminous coal, but excluding lignite, the same below), a year-on-year decrease of 4.
-
"Nutcracker esophagus" clinical diagnosis and treatment, a mind map contains the main points
Time of Update: 2021-04-14
The "nutcracker" esophagus is the most common esophageal pressure disorder in non-cardiogenic chest pain.
However, it also reduces the pressure of the lower esophageal sphincter (LES) and the ability to clear esophageal acid, so it has no therapeutic effect on the "nutcracker" esophagus patients with gastroesophageal reflux disease (GERD), and even aggravates the symptoms.
-
New drugs for depression! Johnson and Johnson Spravato nasal spray approved in the European Union: for patients with severe depression with acute psychosis, rapid reduction of depression
Time of Update: 2021-02-27
-- Johnson and Johnson (JNJ)'s Jansen Pharmaceuticals recently announced that the European Commission (EC) has approved the expansion of Spravato (es) The use of the spray, as an acute short-term treatment drug, in combined with oral antidepressants, is used to treat adult patients with moderate to severe depressive episodes that constitute a psychiatric emergency (MDD) according to clinical judgment, and to rapidly reduce depressive symptoms.
-
Build your core competitiveness through the paint network
Time of Update: 2021-02-14
China Paint Network: , for most small and medium-sized enterprises face low visibility and other issues, in order to promote sales, enterprises should do a good job in the early stage of publicity.
-
Zhengda Sunny won 5 more than $1 billion imitation 32 over-rated varieties bright eyes
Time of Update: 2021-02-10
Pharmaceutical Network February 5th, recently, is day clear pharmaceutical industry happy news: Androtini's fourth adaptive disease was approved, 5 varieties to choose the fourth batch. meters of int
-
New research may help treat sudden cardiac death in young athletes
Time of Update: 2020-12-28
ACM patients usually have mutations in any of the five genes that make up the heart bridge grain.
